Who invested in Tissuetech?
Tissuetech's investors include Ballast Point Ventures, River Cities Capital Funds and EW Healthcare Partners.
United States · Series C startup
7 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$175Mraised across 7 rounds since 2012, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $55M sold, first sale Apr 2019
No investor was named in the report.
Reported by MassdeviceSEC filing: $55M sold, first sale Apr 2019
From a historical funding recordSEC filing: $15M sold, first sale Jun 2015
No investor was named in the report.
Reported by sec.govSEC filing: $1.4M sold, first sale Sept 2013
From a historical funding recordSEC filing: $10M sold, first sale Aug 2013
Reported by finsmes.comSEC filing: $10M sold, first sale Aug 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.4M sold, first sale Sept 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Tissuetech's investors include Ballast Point Ventures, River Cities Capital Funds and EW Healthcare Partners.
Tissuetech has raised $175M across 7 rounds since 2012.
Tissuetech's most recent round was a Series C of $82M in Jun 2019.
Its most recent round, $82M in Jun 2019, is also its largest on record.
Tissuetech's first round on record, in Aug 2013, was backed by River Cities Capital Funds and Ballast Point Ventures.
Tissuetech's latest named round is a Series C, in Jun 2019.
Tissuetech is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.